- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Pegylated recombinant human hyaluronidase PH20
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Pegylated recombinant human hyaluronidase PH20
| EU orphan designation number: | EU/3/14/1394
|
| Active ingredient: | Pegylated recombinant human hyaluronidase PH20 |
| Indication: | Treatment of pancreatic cancer |
| Sponsor: | Pharm Research Associates (UK) Limited
500 South Oak Way, Green Park, Reading, Berkshire RG2 6AD, United Kingdom |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 18/12/2014 | Orphan designation | EMA/OD/173/14 | (2014)10042 of 16/12/2014 |
CONTACT
EU links
Directorate General Health & Consumers